ACAD
32.13
-0.41
-1.26%
AEMD
5.17
-0.08
-1.52%
APRI
0.351
-0.002
-0.4540%
ARNA
1.55
-0.02
-1.27%
ATEC
4
+0.06
+1.52%
CNAT
1.81
-0.07
-3.72%
CRXM
0.168
-0.002
-1.176%
CYTX
2.03
-0.06
-2.87%
DXCM
91.09
-1.04
-1.13%
GNMK
8.52
-0.12
-1.39%
HALO
9.8
-0.08
-0.81%
ILMN
168.34
-0.65
-0.38%
INNV
0.259
-0.024
-8.481%
INO
9.17
-0.28
-2.96%
ISCO
1.8
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
103.31
-1
-0.95%
LPTN
2.35
-0.19
-7.48%
MBVX
4.95
-0.06
-1.20%
MEIP
1.79
-0.11
-5.79%
MNOV
5.89
-0.19
-3.13%
MRTX
5.05
-0.18
-3.44%
MSTX
0.439
+0.01
+2.2605%
NBIX
48.46
-0.71
-1.44%
NUVA
65.47
0.00
0.00%
ONCS
1.692
-0.028
-1.628%
ONVO
3.86
-0.05
-1.28%
OREX
3.93
-0.06
-1.50%
OTIC
16.45
+0.03
+0.18%
QDEL
21.77
+0.03
+0.14%
RCPT
231.96
0.00
0.00%
RGLS
3.17
-0.08
-2.46%
RMD
66.69
-0.53
-0.79%
SPHS
2.98
-0.24
-7.45%
SRNE
6.66
+0.1
+1.52%
TROV
4.91
-0.04
-0.81%
VICL
3.8
-0.05
-1.30%
VOLC
18
0.00
0.00%
ZGNX
8.72
-0.61
-6.54%
ACAD
32.13
-0.41
-1.26%
AEMD
5.17
-0.08
-1.52%
APRI
0.351
-0.002
-0.4540%
ARNA
1.55
-0.02
-1.27%
ATEC
4
+0.06
+1.52%
CNAT
1.81
-0.07
-3.72%
CRXM
0.168
-0.002
-1.176%
CYTX
2.03
-0.06
-2.87%
DXCM
91.09
-1.04
-1.13%
GNMK
8.52
-0.12
-1.39%
HALO
9.8
-0.08
-0.81%
ILMN
168.34
-0.65
-0.38%
INNV
0.259
-0.024
-8.481%
INO
9.17
-0.28
-2.96%
ISCO
1.8
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
103.31
-1
-0.95%
LPTN
2.35
-0.19
-7.48%
MBVX
4.95
-0.06
-1.20%
MEIP
1.79
-0.11
-5.79%
MNOV
5.89
-0.19
-3.13%
MRTX
5.05
-0.18
-3.44%
MSTX
0.439
+0.01
+2.2605%
NBIX
48.46
-0.71
-1.44%
NUVA
65.47
0.00
0.00%
ONCS
1.692
-0.028
-1.628%
ONVO
3.86
-0.05
-1.28%
OREX
3.93
-0.06
-1.50%
OTIC
16.45
+0.03
+0.18%
QDEL
21.77
+0.03
+0.14%
RCPT
231.96
0.00
0.00%
RGLS
3.17
-0.08
-2.46%
RMD
66.69
-0.53
-0.79%
SPHS
2.98
-0.24
-7.45%
SRNE
6.66
+0.1
+1.52%
TROV
4.91
-0.04
-0.81%
VICL
3.8
-0.05
-1.30%
VOLC
18
0.00
0.00%
ZGNX
8.72
-0.61
-6.54%
Home » Archive by Category

Xconomy

What’s Ahead for Biotech in 2016: Q&A With BIO Chair Ron Cohen

March 31, 2016 – 6:55 am

Biotechnology is a tricky business. We all know the trials and tribulations—and costs—of bringing novel drugs to market. In the past six months or so, a new round of drug pricing upheaval…

[[Click headline to continue reading.]]

New PureTech Startup Commense Aims to Protect Babies From Disease

March 31, 2016 – 5:50 am

[Updated, 12:15 pm ET, see below] Boston company creator PureTech Health already has one microbiome startup in its portfolio, Vedanta Biosciences. Today it’s unveiled a second one, Commense, with a…

[[Click headline to continue reading.]]

The Xconversation: Vaccine Developer Meets Energy Innovator, Part II

March 30, 2016 – 3:20 am

There’s no such thing as failure, as long as you view it in the proper light. That’s the philosophy of scientist-entrepreneurs Darrick Carter, vice president of adjuvant technology at…

[[Click headline to continue reading.]]

The Xconversation: Vaccine Developer Meets Energy Innovator, Part I

March 29, 2016 – 3:20 am

What do vaccines have to do with batteries? Let your mind’s eye travel to the cellular membrane, where a ligand is enveloped by a receptor, spurring a subtle change in the cell. (Bear with me.)…

[[Click headline to continue reading.]]

West Coast Bio Roundup: Gilead, Affymetrix, Acutus, Frazier & More

March 25, 2016 – 7:13 am

Gilead Sciences is back at the top of our chart for the second week in a row. After halting trials last week in the United States and Europe over its cancer drug idelalisib, a federal jury in San…

[[Click headline to continue reading.]]

CRISPR And Beyond: UCSD-Doudna Work Attracts Paul Allen’s Millions

March 23, 2016 – 2:33 pm

CRISPR-Cas9 is well known, by people who follow science and some who don’t, as the new DNA editing tool that one day might cure genetic diseases or lead to designer babies. Or both. Whether…

[[Click headline to continue reading.]]

Gilman Scores for Atlas Again as Bristol Buys Padlock for up to $600M

March 23, 2016 – 5:42 am

For the second time in just over four years, former Biogen research executive Michael Gilman has steered a startup towards a buyout. This time, it’s Padlock Therapeutics, a fledgling developer of…

[[Click headline to continue reading.]]

Dear Biopharma: Give Us Better Therapies for Pain

March 23, 2016 – 12:00 am

The CDC released on March 15th new guidelines that advise strict limits on the prescription of opioids for pain. These guidelines respond to a stunning increase in deaths and addiction related to the…

[[Click headline to continue reading.]]

Acutus Medical Raises $75M to Map Abnormal Currents of the Heart

March 22, 2016 – 3:00 am

Acutus Medical, a suburban San Diego medical device maker with new technology for diagnosing and treating irregular heartbeats, said today it has closed on $75 million in Series C funding. The…

[[Click headline to continue reading.]]

Big Data Meets Big Biology in San Diego, and Tickets Are Going Fast

March 22, 2016 – 12:00 am

Less than 15 tickets remain for next week’s Xconomy forum on Big Data Meets Big Biology. Join innovators in both data science and the life sciences on March 31st as they discuss how they are…

[[Click headline to continue reading.]]